Literature DB >> 9719376

De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.

C Dumanchin1, A Brice, D Campion, D Hannequin, C Martin, V Moreau, Y Agid, M Martinez, F Clerget-Darpoux, T Frebourg.   

Abstract

The presenilin 1 (PS1) gene, located on chromosome 14, is the major gene involved in the autosomal dominant forms of early onset Alzheimer's disease (AD). In order to estimate the frequency of de novo PS1 mutations, we have sequenced the PS1 open reading frame in 13 clinically diagnosed patients with no affected relatives, who had developed AD before the age of 50. In one case with onset at 37 years, we identified a missense mutation resulting in a methionine to lysine substitution at codon 139 of the PS1 gene. This substitution is the fourth identified at the same codon. This study, in agreement with previous reports, suggests that de novo PS1 mutations can occur but at a low frequency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9719376      PMCID: PMC1051395          DOI: 10.1136/jmg.35.8.672

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.

Authors:  D Campion; A Brice; C Dumanchin; M Puel; M Baulac; V De La Sayette; D Hannequin; C Duyckaerts; A Michon; C Martin; V Moreau; C Penet; M Martinez; F Clerget-Darpoux; Y Agid; T Frebourg
Journal:  Neuroreport       Date:  1996-07-08       Impact factor: 1.837

2.  Missense mutations of the PS-1/S182 gene in German early-onset Alzheimer's disease patients.

Authors:  R Sandbrink; D Zhang; S Schaeffer; C L Masters; J Bauer; H Förstl; K Beyreuther
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

Review 3.  The gene defects responsible for familial Alzheimer's disease.

Authors:  R E Tanzi; D M Kovacs; T W Kim; R D Moir; S Y Guenette; W Wasco
Journal:  Neurobiol Dis       Date:  1996       Impact factor: 5.996

4.  Assignment of Alzheimer's presenilin-2 (PS-2) gene to 1q42.1 by fluorescence in situ hybridization.

Authors:  T Takano; N Sahara; Y Yamanouchi; H Mori
Journal:  Neurosci Lett       Date:  1997-01-17       Impact factor: 3.046

5.  Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients.

Authors:  H Tanahashi; S Kawakatsu; M Kaneko; H Yamanaka; K Takahashi; T Tabira
Journal:  Neurosci Lett       Date:  1996-11-01       Impact factor: 3.046

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene.

Authors:  E I Rogaev; R Sherrington; E A Rogaeva; G Levesque; M Ikeda; Y Liang; H Chi; C Lin; K Holman; T Tsuda
Journal:  Nature       Date:  1995-08-31       Impact factor: 49.962

8.  Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.

Authors:  D Campion; J M Flaman; A Brice; D Hannequin; B Dubois; C Martin; V Moreau; F Charbonnier; O Didierjean; S Tardieu
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

9.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus.

Authors:  E Levy-Lahad; W Wasco; P Poorkaj; D M Romano; J Oshima; W H Pettingell; C E Yu; P D Jondro; S D Schmidt; K Wang
Journal:  Science       Date:  1995-08-18       Impact factor: 47.728

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  11 in total

1.  Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons.

Authors:  Gaël Nicolas; David Wallon; Camille Charbonnier; Olivier Quenez; Stéphane Rousseau; Anne-Claire Richard; Anne Rovelet-Lecrux; Sophie Coutant; Kilan Le Guennec; Delphine Bacq; Jean-Guillaume Garnier; Robert Olaso; Anne Boland; Vincent Meyer; Jean-François Deleuze; Hans Markus Munter; Guillaume Bourque; Daniel Auld; Alexandre Montpetit; Mark Lathrop; Lucie Guyant-Maréchal; Olivier Martinaud; Jérémie Pariente; Adeline Rollin-Sillaire; Florence Pasquier; Isabelle Le Ber; Marie Sarazin; Bernard Croisile; Claire Boutoleau-Bretonnière; Catherine Thomas-Antérion; Claire Paquet; Mathilde Sauvée; Olivier Moreaud; Audrey Gabelle; François Sellal; Mathieu Ceccaldi; Ludivine Chamard; Frédéric Blanc; Thierry Frebourg; Dominique Campion; Didier Hannequin
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Presenilin 2 Ser130Leu mutation in a case of late-onset "sporadic" Alzheimer's disease.

Authors:  Carmine Tomaino; Livia Bernardi; Maria Anfossi; Angela Costanzo; Francesca Ferrise; Maura Gallo; Silvana Geracitano; Raffaele Maletta; Sabrina A M Curcio; Maria Mirabelli; Rosanna Colao; Francesca Frangipane; Gianfranco Puccio; Cinzia Calignano; Maria Gabriella Muraca; Annamaria Paonessa; Nicoletta Smirne; Attilio Leotta; Amalia C Bruni
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

4.  Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.

Authors:  Miryam Carecchio; Marina Picillo; Lorella Valletta; Antonio E Elia; Tobias B Haack; Autilia Cozzolino; Annalisa Vitale; Barbara Garavaglia; Arcangela Iuso; Caterina F Bagella; Sabina Pappatà; Paolo Barone; Holger Prokisch; Luigi Romito; Valeria Tiranti
Journal:  Neurogenetics       Date:  2017-06-29       Impact factor: 2.660

5.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

6.  De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease.

Authors:  A Rovelet-Lecrux; C Charbonnier; D Wallon; G Nicolas; M N J Seaman; C Pottier; S Y Breusegem; P P Mathur; P Jenardhanan; K Le Guennec; A S Mukadam; O Quenez; S Coutant; S Rousseau; A-C Richard; A Boland; J-F Deleuze; T Frebourg; D Hannequin; D Campion
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

Review 7.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

8.  APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Authors:  Hélène-Marie Lanoiselée; Gaël Nicolas; David Wallon; Anne Rovelet-Lecrux; Morgane Lacour; Stéphane Rousseau; Anne-Claire Richard; Florence Pasquier; Adeline Rollin-Sillaire; Olivier Martinaud; Muriel Quillard-Muraine; Vincent de la Sayette; Claire Boutoleau-Bretonniere; Frédérique Etcharry-Bouyx; Valérie Chauviré; Marie Sarazin; Isabelle le Ber; Stéphane Epelbaum; Thérèse Jonveaux; Olivier Rouaud; Mathieu Ceccaldi; Olivier Félician; Olivier Godefroy; Maite Formaglio; Bernard Croisile; Sophie Auriacombe; Ludivine Chamard; Jean-Louis Vincent; Mathilde Sauvée; Cecilia Marelli-Tosi; Audrey Gabelle; Canan Ozsancak; Jérémie Pariente; Claire Paquet; Didier Hannequin; Dominique Campion
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

Review 9.  The role of de novo mutations in adult-onset neurodegenerative disorders.

Authors:  Gaël Nicolas; Joris A Veltman
Journal:  Acta Neuropathol       Date:  2018-11-26       Impact factor: 17.088

Review 10.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.